FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
forum

CAPLIPOINT Share Price Discussion

Caplin Point Laboratories Ltd.
Sector: Pharmaceuticals and health care
... Read more
CAPLIPOINT Long Term Analysts Rating
0/5 (0 Ratings)
CAPLIPOINT Share Price *
294.55 -0.35 (-0.12%)
* (quote may be delayed)

Find answers to all your questions on live CAPLIPOINT message board: Is CAPLIPOINT buy or sell? Should I buy CAPLIPOINT shares? Why are CAPLIPOINT shares falling? Should I invest in CAPLIPOINT stock?


CAPLIPOINT Discussion Forum

@bullionking • Reputation: 6,115
CAPLIPOINT

Type
Buy
Instrument
CAPLIPOINT
Entry Price
₹300.5
Price@Trade
₹300.1
Target Price
₹312
Stop Price
₹290
Valid Till
Dec 31, 2020 3:20 PM  Feb 11, 2021 3:20 PM
Margin
₹300.5 approx for 1 Qty
Status
Stoploss Hit
Net P&L
-3.49% Loss
1
reply
Reply (3)
Latest replies
Bullion_King @bullionking
Dec 31 4:16 PM

Update
Time Extended
Price @ Update
₹300
Original Time
Dec 31, 2020 3:20 PM
New Time
Feb 11, 2021 3:20 PM
TrackerBot @trackerbot
Dec 31 4:24 PM

Update
Trade Entered
Entry Price
₹300.5
TrackerBot @trackerbot
Jan 6 8:51 PM

Update
Stoploss Hit
StopLoss
₹290
@bullionking • Reputation: 6,115
CAPLIPOINT

Type
Buy
Instrument
CAPLIPOINT
Entry Price
₹304
Price@Trade
₹304.15
Target Price
₹309
Stop Price
₹299
Valid Till
Jan 3, 2020 3:20 PM
Margin
₹304 approx for 1 Qty
Status
Stoploss Hit
Net P&L
-1.64% Loss
BUY CAPLIPOINT @304-302
SL 299
TGT 308--310/315++
Like
reply
Reply (2)
Latest replies
TrackerBot @trackerbot
Dec 27 5:42 PM

Update
Trade Entered
Entry Price
₹304
TrackerBot @trackerbot
Dec 31 4:06 PM

Update
Stoploss Hit
StopLoss
₹299
@rm9ine • Reputation: 0

Why is it falling like anything?
Like
reply
Reply (2)
Latest replies

Data Negative
RM9ine @rm9ine
Dec 12 2:48 AM

Can you please explain?
@umanath • Reputation: 563

CAPLIPOINT - 418489

Like
reply
Reply
@newsbot • Reputation: 1,933
Time to buy ‘fear’? Top 10 stocks based on Warren Buffett investment methodology
Although market gurus have time and again said that the best time to buy is when there is fear on the street, it is a difficult strategy to implement.
moneycontrol.com
Like
reply
Reply
@newsbot • Reputation: 1,933
Like
reply
Reply
@newsbot • Reputation: 1,933
Like
reply
Reply
@newsbot • Reputation: 1,933
Like
reply
Reply
@guptan • Reputation: 2,839

CAPLIPOINT - chart - 241741
Caplinpoint
Like
reply
Reply
@newsbot • Reputation: 1,933
Like
reply
Reply
@newsbot • Reputation: 1,933
Like
reply
Reply
@newsbot • Reputation: 1,933
Like
reply
Reply
@guptan • Reputation: 2,839

Caplinpoint
CAPLIPOINT - chart - 208305
Like
reply
Reply
@newsbot • Reputation: 1,933
Like
reply
Reply
@newsbot • Reputation: 1,933
Like
reply
Reply
@newsbot • Reputation: 1,933
Like
reply
Reply
@newsbot • Reputation: 1,933
Like
reply
Reply
@newsbot • Reputation: 1,933
Like
reply
Reply
@newsbot • Reputation: 1,933
Like
reply
Reply
@newsbot • Reputation: 1,933
Like
reply
Reply
@newsbot • Reputation: 1,933
Like
reply
Reply
  • CAPLIPOINT - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization3,043.78
    Enterprise Value2,998.93
    Price to Earnings42.47
    Price to Book Value7.05
    Return on Capital Employed0.5
    Return on Equity0.35
    Face Value2
    Dividend YieldNA
  • CAPLIPOINT Share Price - Technicals

    keyboard_arrow_down
    CAPLIPOINT - 52 Week High₹466.9
    CAPLIPOINT - 52 Week Low₹280.1
  • CAPLIPOINT Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Jan 22296.9299.4294.2295.9
    Jan 21298.5298.75291.15294.9
    Jan 20305307.5294295.5
    Jan 17309.7309.7301302.75
    Jan 16295315.05294.4304.9
  • CAPLIPOINT Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹296.14
    30 Day Moving Average₹299.42
    50 Day Moving Average₹311.33
    100 Day Moving Average₹360.44
    200 Day Moving Average₹381.29
  • CAPLIPOINT - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue427344.360.24
    Operating Profit14397.60.47
    Profit Before Tax14693.410.56
    Net Income10270.860.44
  • CAPLIPOINT - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds4322950.46
    Total Liabilities107116-0.08
    Total Assets5394110.31
  • CAPLIPOINT - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity2155.71-0.62
    Cash from Investing Activity-58-37.070.56
    Cash from Financing Activity-12-6.740.78
    Net Cash Flow-4911.89-5.12
  • CAPLIPOINT - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.250.22
    Return on Equity0.350.36
    Return on Capital Employed0.50.48
  • CAPLIPOINT - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.78
    3 Year CAGR Growth in Operating Profit1.5
    3 Year CAGR Growth in EBIDTA1.77
    3 Year CAGR Growth in Net Income1.49
    3 Yr CAGR Growth - Diluted EPS-0.5
  • CAPLIPOINT - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue2.48
    5 Year CAGR Growth in Operating Profit5.51
    5 Year CAGR Growth in EBIDTA6
    5 Year CAGR Growth in Net Income6.13
    3 Yr CAGR Growth - Diluted EPS0.42
  • CAPLIPOINT - Recent News

    keyboard_arrow_down
    NewsBot
    Aug 5 4:48 PM
    Time to buy ‘fear’? Top 10 stocks based on Warren Buffett investment methodology
    moneycontrol.com
    NewsBot
    Jul 25 10:28 PM
    NewsBot
    Jul 25 5:33 PM
    NewsBot
    Jul 18 7:18 PM
    NewsBot
    Jun 17 6:13 PM
    NewsBot
    Jun 14 7:13 PM
    NewsBot
    Jun 14 4:18 PM
    NewsBot
    May 22 8:33 PM
    NewsBot
    May 22 8:33 PM
    NewsBot
    Apr 8 5:13 PM
  • CAPLIPOINT - Related Communities

    keyboard_arrow_down
    Sun Pharmaceutical Industries Ltd. S...
    Aurobindo Pharma Ltd. Sector: Pharma...
    Biocon Ltd. Sector: Pharmaceuticals ...
    Cipla Ltd. Sector: Pharmaceuticals a...
    Lupin Ltd. Sector: Pharmaceuticals an...
    Dr. Reddy's Laboratories Ltd. Sector...
    Piramal Enterprises Ltd. Sector: Phar...
    Glenmark Pharmaceuticals Ltd. Sector...
    Divi's Laboratories Ltd. Sector: Pha...
    Strides Pharma Science Ltd. Sector: P...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.